Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1731767 | 0.92 | CCR4 (0.78) | CCR4EDNRA | |
| SCHEMBL1732683 | 0.91 | CCR4 (0.70) | CCR4 | |
| SCHEMBL1732386 | 0.89 | CCR4 (0.76) | CCR4EDNRA | |
| SCHEMBL1732789 | 0.86 | CCR4 (0.74) | CCR4 | |
| SCHEMBL1733380 | 0.80 | CCR4 (0.94) | CCR4EDNRA | |
| SCHEMBL1731719 | 0.80 | CCR4 (0.79) | CCR4 | |
| SCHEMBL1732021 | 0.80 | CCR4 (0.90) | CCR4EDNRA | |
| SCHEMBL1732895 | 0.79 | CCR4 (0.81) | CCR4EDNRA | |
| SCHEMBL1732592 | 0.79 | CCR4 (0.72) | CCR4EDNRA | |
| SCHEMBL1733087 | 0.78 | CCR4 (0.62) | CCR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1467976-A1 | N-PYRAZINYL-PHENYLSULPHONAMIDES AND THEIR USE IN THE TREATMENT OF CHEMOKINE MEDIATED DISEASES | AstraZeneca AB (SE) | 2004-10-20 | — | — | EP | claimed |
| WO-2003059893-A1 | N-PYRAZINYL-PHENYLSULPHONAMIDES AND THEIR USE IN THE TREATMENT OF CHEMOKINE MEDIATED DISEASES | ASTRAZENECA AB (SE) | 2003-07-24 | — | — | WO | claimed |